Pay in 4 interest-free payments of $5.05 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
This combined therapy might not only reduce weight but also improve overall metabolic health, addressing issues like insulin resistance, fat distribution, and hormonal imbalances simultaneously
However, because AOD-9604 does not affect appetite or insulin sensitivity, having breakfast immediately after administration does not appear to interfere with the peptides fat tissue effects, making timing more flexible than with compounds that rely on specific insulin or glucose states
Step 2: Get a Prescription Next, check with your healthcare provider whether you meet the criteria to be prescribed Mounjaro for type 2 diabetes or Zepbound for weight management or moderate to severe obstructive sleep apnea (OSA)
In September 2025, Novo Nordisk said it will test its obesity/GLP-1 drugs in conditions like sleep apnea and knee osteoarthritis
